The investement team consists of Anders Tuv, Chief Investment Officer and Jónas Einarsson, CEO. We work hands-on and dedicated with selected start-up companies in the immune-oncology sector. We possess first-hand knowledge of the sector and function as active business strategy partners and advisors to the companies we invest in. Anders Tuv or Jónas Einarsson are company board members or Chairman of the board of RADFORSK portfolio companies and also take on operational tasks, at the early stage. With year-long knowledge and experience with early stage research-based companies in the immune-oncology sector we thus minimize investment risks. See our track record.